SCHEMBL29311349

SCHEMBL29311349

c1ccc(-c2cccc(-c3nc(-c4ccc5sc(-c6ccccc6)nc5c4)nc(-n4c5ccccc5c5ccccc54)n3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.42
▸ NFKB1 P19838 7/20 0.42
▸ NFKB2 Q00653 7/20 0.42
▸ RELA Q04206 7/20 0.42
▸ KDM4E B2RXH2 6/20 0.42
▸ NPC1 O15118 6/20 0.42
▸ MAPT P10636 6/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ GAA P10253 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ GFER P55789 1/20 0.42
▸ HPGD P15428 3/20 0.40
▸ STAT1 P42224 1/20 0.40
▸ APP P05067 2/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ SMN1; SMN2 Q16637 6/20 0.39
▸ LMNA P02545 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29311347 0.95 RAB9A (0.44) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL25459616 0.94 RAB9A (0.45) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL29311350 0.91 RAB9A (0.42) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL29311291 0.91 KDM4E (0.47) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL15430982 0.90 KDM4E (0.41) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL27049592 0.89 KDM4E (0.47) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL29311358 0.88 KDM4E (0.40) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL29311356 0.88 APP (0.41) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL27049296 0.87 RAB9A (0.43) RAB9ANFKB1NFKB2RELAKDM4E
SCHEMBL29311362 0.87 RAB9A (0.43) RAB9ANFKB1NFKB2RELAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 — — US disclosed
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237519-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND NLRP3, NLRP1, TYR RAB9A 4296/4885NFKB1 1419/4885NFKB2 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback